Pharma Pricing & Market Access Innovation Summit

Key topics

• EU HTA Implementation: Impacts of the EU Health Technology Assessment regulation on market access strategies.
• Innovative Pricing Models: Including outcomes-based pricing, subscription models, and managed entry agreements.
• Global Access and Equity: Strategies to improve access in emerging markets and underserved regions.
• Real-World Evidence (RWE) & Data Use: Enhancing pricing decisions and HTA submissions with real-world data.
• Digital Health & Innovation: The role of digital tools in market access and patient outcomes.
• Rare Diseases & Orphan Drugs: Navigating the unique pricing and access challenges in rare disease treatments.
• Health Economics & Value Frameworks: Evolving value assessments and cost-effectiveness evaluations.
• Patient-Centered Access: Incorporating patient perspectives in access planning and value demonstration.
• Policy Trends & Regulation: Navigating international pricing reforms and evolving policy landscapes.

Who should attend

CEOs, CMOs, VPs, Directors, Managers, Heads specialising in:

• HEOR
• Patient Access
• Market Access
• Drug Pricing
• Health Economics
• Healthcare Affairs
• Reimbursement
• Oncology
• Vaccines
• Real World Evidence
• Business Development
• Product Launch
• Tendering
• Clinical Research and Development
• Regulatory Affairs
• Patient Outcomes
• Epidemiology
• Government Affairs
• Value Strategy
• Marketing

Target audience

• Pharmaceutical Companies
• Biotech Companies
• Clinical Research Organizations
• International and Regional Health Authorities and Regulators
• Technology Vendors
• Business Process Outsourcing
• Healthcare Systems